Published in

Elsevier, Neuroscience Letters, 2-3(302), p. 117-120

DOI: 10.1016/s0304-3940(01)01688-3

Links

Tools

Export citation

Search in Google Scholar

Glycogen synthase kinase-3β immunoreactivity is reduced in the prefrontal cortex in schizophrenia

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Cytoarchitectural abnormalities have been reported in the cortex in schizophrenia. These suggest a developmental origin for this disorder. The Wnt signalling pathway is involved in the regulation of brain development; disruption of this pathway may lead to abnormal cortical development. In this study levels of three components of the Wnt signalling pathway; glycogen synthase kinase-3 beta (GSK-3 beta), beta -catenin and dishevelled-2 (Dvl-2) were determined in the prefrontal cortex of ten schizophrenic and ten control individuals using immunoblotting. GSK-3 beta levels were significantly reduced in the schizophrenic group, while levels of beta -catenin and Dvl-2 did not differ between groups. This provides further evidence for an abnormality of the Wnt signalling pathway in schizophrenia. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.